Halozyme Therapeutics Inc (HALO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.43B
Last updated: Nov 17, 2026 at 11:06 AM ET
Halozyme Therapeutics Inc (HALO) Competitors
The companies most similar to Halozyme Therapeutics are Exelixis (EXEL), Summit Therapeutics (SMMT) and BridgeBio Pharma (BBIO). Halozyme Therapeutics trades at 17.8x earnings, against a median of 39.6x for the 7 of these companies with a P/E. By market cap, Halozyme Therapeutics ranks 5th of the 13 companies on this page; Exelixis (EXEL) is the largest at $16.84B.
Peer Comparison
HALO's ROIC of 15.8% is above the peer median of 1.8%, and its revenue growth of 39.2% is above the median of 20.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Halozyme Therapeutics (HALO) | $11.43B | 17.8x | 6.1x | 26.9% | 15.8% | 39.2% | 0.00% |
| Exelixis Inc (EXEL) | $16.84B | 19.3x | 6.9x | 35.4% | N/A | 10.2% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Apogee Therapeutics, Inc. Common Stock (APGE) | $10.22B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Jazz Pharmaceuticals PLC (JAZZ) | $15.50B | 18.4x | 3.3x | 4.4% | 3.5% | 10.4% | 0.00% |
| Kymera Therapeutics Inc (KYMR) | $10.89B | N/A | 123.2x | 0.0% | N/A | 466.4% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Bio-Techne Corp (TECH) | $11.44B | 39.6x | 9.3x | 14.0% | 7.7% | 4.6% | 0.44% |
| Ligand Pharmaceuticals Incorporated (LGND) | $6.18B | 66.5x | 23.7x | 20.3% | 0.1% | -31.8% | 0.00% |
| Krystal Biotech Inc (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| Axsome Therapeutics Inc (AXSM) | $7.45B | N/A | 8.6x | -18.2% | -48.1% | 51.9% | 0.00% |
| Peer median | $10.56B | 39.6x | 13.4x | 8.1% | 1.8% | 20.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to Halozyme Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Exelixis Inc (EXEL) | Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development... | EXEL competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
| BridgeBio Pharma Inc (BBIO) | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Apogee Therapeutics, Inc. Common Stock (APGE) | Apogee Therapeutics, Inc., through its subsidiary, is a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD)... | |
| Jazz Pharmaceuticals PLC (JAZZ) | Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United... | JAZZ competitors |
| Kymera Therapeutics Inc (KYMR) | Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down... | KYMR competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Bio-Techne Corp (TECH) | Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments... | TECH competitors |
| Ligand Pharmaceuticals Incorporated (LGND) | Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover... | LGND competitors |
| Krystal Biotech Inc (KRYS) | Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United... | KRYS competitors |
| Axsome Therapeutics Inc (AXSM) | Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United... | AXSM competitors |
Frequently Asked Questions About HALO
Who are Halozyme Therapeutics' main competitors?
The companies most similar to Halozyme Therapeutics include Exelixis (EXEL), Summit Therapeutics (SMMT), BridgeBio Pharma (BBIO), TG Therapeutics (TGTX) and Apogee Therapeutics, Inc. Common Stock (APGE), listed from the closest match.
Who is Halozyme Therapeutics' biggest competitor?
Exelixis (EXEL) is both the largest of the similar companies at $16.84B and the closest match by business profile, size, sector and industry.
How does HALO stock compare with its competitors?
HALO's P/E is 17.8x against a peer median of 39.6x; its P/S is 6.1x against a peer median of 13.4x; its net margin is 26.9% against a peer median of 8.1%.
Which of Halozyme Therapeutics' competitors pays a higher dividend?
Halozyme Therapeutics pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.
Is Halozyme Therapeutics bigger than its competitors?
No. Halozyme Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Exelixis (EXEL) at $16.84B.
HALO pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors